National Diabetes Clinical Care Commission Act of 2015

Today, total national costs associated with diabetes are $322 billion and one out of every three Medicare dollars is spent on people with diabetes. There are currently 35 federal agencies are involved in diabetes care and treatment, however they are largely uncoordinated and likely redundant.

In March 2015, Rep. Pete Olson (R-TX-22) and Sen. Jeanne Shaheen (D-NH) introduced the National Diabetes Clinical Care Commission Act of 2015 (H.R.1192 in the House and S.586 in the Senate) to establish a commission that will focus on improving diabetes care delivery and patient outcomes and reducing costs.

The commission will be comprised of diabetes experts including endocrinologists and other specialists that treat the complications of diabetes, primary care physicians, patient advocates, and representatives from the federal agencies most involved in diabetes care.

Support for the National Diabetes Prevention Program

The National Diabetes Prevention Program (National DPP) is helping make it possible for affordable and effective diabetes prevention programs to be available in communities across the country.

Novo Nordisk and other members of the Diabetes Advocacy Alliance are asking Congress to support $20 million for the National DPP in the government’s budget for fiscal year 2017. These funds would allow the National DPP to be “scaled up” with more sites in hundreds of communities across the country, helping to reach thousands of adults with prediabetes and help them take control of their health

Special Diabetes Program

ACT for Diabetes works with the American Diabetes Association, Juvenile Diabetes Research Foundation, and others in the diabetes community to encourage Congress to maintain support for the Special Diabetes Program (SDP), which is critical in the fight against diabetes. The Special Diabetes Program includes two fundamentally important initiatives:

These two programs began in 1997. In April 2015, Congress renewed the Special Diabetes Programs for two years and it is now set to expire in September of 2017.

Preventative Health Savings Act

Healthcare costs associated with diabetes and its complications continue to reach record highs. But what would those costs look like if we had diabetes preventive measures in place?

Between 2015 and 2016, Rep. Michael Burgess (R-TX-26) and Sen. Angus King (I-ME) introduced a bill to amend the Congressional Budget Act of 1974 respecting the scoring of Preventive Health Savings (H.R.3660 and S.3126).

This legislation would allow the Congressional Budget Office (CBO) to examine the costs of preventive health interventions, such as treatments to prevent the complications of diabetes, or programs to prevent the onset of diabetes, over a period of time that is longer than the current ten-year window used by CBO.

Funding for Research at NIH and CDC

Research supported by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) offers the best hope for finding a cure for diabetes, and preventing the onset of the disease and its many serious complications.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) funds a variety of research studies and projects related to prevention, treatment, and cures for all types of diabetes.

The CDC supports research that takes what is learned from basic and clinical research studies, and “translates” it so that it can be used in real-world settings.